Cargando...
Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents
Approaches to develop effective drugs to kill cancer cells are mainly focused either on the improvement of the currently used chemotherapeutics or on the development of targeted therapies aimed at the selective destruction of cancer cells by steering specific molecules and/or enhancing the immune re...
Guardado en:
| Publicado en: | Pharmaceutics |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7828032/ https://ncbi.nlm.nih.gov/pubmed/33435285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13010082 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|